Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2015 1
2016 1
2017 2
2018 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
P2X7 antagonists for CNS indications: recent patent disclosures.
Pevarello P, Bovolenta S, Tarroni P, Za L, Severi E, Torino D, Vitalone R. Pevarello P, et al. Among authors: bovolenta s. Pharm Pat Anal. 2017 Mar;6(2):61-76. doi: 10.4155/ppa-2016-0044. Epub 2017 Mar 1. Pharm Pat Anal. 2017. PMID: 28248151 Review.
Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: bovolenta s. Sci Rep. 2017 Sep 8;7(1):10999. doi: 10.1038/s41598-017-11194-0. Sci Rep. 2017. PMID: 28887460 Free PMC article.
Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.
Gemei M, Talarico C, Brandolini L, Manelfi C, Za L, Bovolenta S, Liberati C, Vecchio LD, Russo R, Cerchia C, Allegretti M, Beccari AR. Gemei M, et al. Among authors: bovolenta s. Int J Mol Sci. 2020 Oct 16;21(20):7677. doi: 10.3390/ijms21207677. Int J Mol Sci. 2020. PMID: 33081372 Free PMC article.
Publisher Correction: Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: bovolenta s. Sci Rep. 2018 Mar 6;8(1):4250. doi: 10.1038/s41598-018-21902-z. Sci Rep. 2018. PMID: 29511237 Free PMC article.
DFL23448, A Novel Transient Receptor Potential Melastin 8-Selective Ion Channel Antagonist, Modifies Bladder Function and Reduces Bladder Overactivity in Awake Rats.
Mistretta FA, Russo A, Castiglione F, Bettiga A, Colciago G, Montorsi F, Brandolini L, Aramini A, Bianchini G, Allegretti M, Bovolenta S, Russo R, Benigni F, Hedlund P. Mistretta FA, et al. Among authors: bovolenta s. J Pharmacol Exp Ther. 2016 Jan;356(1):200-11. doi: 10.1124/jpet.115.228684. Epub 2015 Nov 6. J Pharmacol Exp Ther. 2016. PMID: 26546575